Baldwin Wealth Partners’s Eterna Therapeutics ERNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-570
| Closed | -$8.97K | – | 486 |
|
|
2024
Q3 | $8.97K | Hold |
570
| – | – | ﹤0.01% | 811 |
|
|
2024
Q2 | $15.6K | Hold |
570
| – | – | ﹤0.01% | 496 |
|
|
2024
Q1 | $20.5K | Hold |
570
| – | – | ﹤0.01% | 486 |
|
|
2023
Q4 | $15.3K | Sell |
570
-61
| -10% | -$1.64K | ﹤0.01% | 531 |
|
|
2023
Q3 | $20.6K | Hold |
631
| – | – | ﹤0.01% | 507 |
|
|
2023
Q2 | $21.4K | Hold |
631
| – | – | ﹤0.01% | 526 |
|
|
2023
Q1 | $32.2K | Buy |
631
+18
| +3% | +$918 | ﹤0.01% | 482 |
|
|
2022
Q4 | $29.6K | Buy |
613
+478
| +354% | +$23.1K | ﹤0.01% | 492 |
|
|
2022
Q3 | $10K | Hold |
135
| – | – | ﹤0.01% | 519 |
|
|
2022
Q2 | $21K | Buy |
135
+6
| +5% | +$933 | ﹤0.01% | 466 |
|
|
2022
Q1 | $79K | Hold |
129
| – | – | 0.01% | 309 |
|
|
2021
Q4 | $161K | Hold |
129
| – | – | 0.02% | 218 |
|
|
2021
Q3 | $359K | Sell |
129
-18
| -12% | -$50.1K | 0.04% | 147 |
|
|
2021
Q2 | $795K | Buy |
+147
| New | +$795K | 0.09% | 83 |
|